DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,090,001 | +4.6% | 60,822 | +1.2% | 3.51% | +8.9% |
| Q2 2023 | $14,421,965 | -4.8% | 60,092 | -0.0% | 3.22% | -10.6% |
| Q1 2023 | $15,148,785 | -5.4% | 60,105 | -0.4% | 3.61% | -6.7% |
| Q4 2022 | $16,012,254 | +1.7% | 60,328 | -1.1% | 3.87% | -5.4% |
| Q3 2022 | $15,750,000 | +1.2% | 60,977 | -0.7% | 4.08% | +9.5% |
| Q2 2022 | $15,567,000 | -15.0% | 61,402 | -1.7% | 3.73% | +2.4% |
| Q1 2022 | $18,318,000 | -15.3% | 62,450 | -5.0% | 3.64% | -2.2% |
| Q4 2021 | $21,637,000 | +7.7% | 65,765 | -0.4% | 3.72% | -2.1% |
| Q3 2021 | $20,092,000 | +10.4% | 65,998 | -2.7% | 3.80% | +13.4% |
| Q2 2021 | $18,195,000 | +16.5% | 67,799 | -2.3% | 3.36% | +12.7% |
| Q1 2021 | $15,618,000 | -4.2% | 69,389 | -5.5% | 2.98% | -5.6% |
| Q4 2020 | $16,303,000 | +3.3% | 73,391 | +0.1% | 3.15% | -8.4% |
| Q3 2020 | $15,781,000 | +20.4% | 73,289 | -1.1% | 3.44% | +10.5% |
| Q2 2020 | $13,109,000 | +26.7% | 74,133 | -0.9% | 3.12% | +12.9% |
| Q1 2020 | $10,349,000 | -11.9% | 74,773 | -2.3% | 2.76% | +12.1% |
| Q4 2019 | $11,748,000 | +3.5% | 76,547 | -2.6% | 2.46% | -6.7% |
| Q3 2019 | $11,354,000 | +1.5% | 78,607 | +0.4% | 2.64% | +5.1% |
| Q2 2019 | $11,187,000 | +7.1% | 78,275 | -1.1% | 2.51% | +4.3% |
| Q1 2019 | $10,446,000 | +29.8% | 79,127 | +1.4% | 2.41% | +11.7% |
| Q4 2018 | $8,048,000 | -5.2% | 78,037 | -0.1% | 2.15% | +11.7% |
| Q3 2018 | $8,490,000 | +16.6% | 78,134 | +5.9% | 1.93% | +6.8% |
| Q2 2018 | $7,283,000 | +1.1% | 73,810 | +0.3% | 1.81% | -1.0% |
| Q1 2018 | $7,207,000 | +5.8% | 73,607 | +0.3% | 1.82% | +4.1% |
| Q4 2017 | $6,814,000 | +20.7% | 73,418 | +11.6% | 1.75% | +2.6% |
| Q3 2017 | $5,644,000 | +0.3% | 65,797 | -1.3% | 1.71% | -2.7% |
| Q2 2017 | $5,628,000 | +1.1% | 66,693 | +2.4% | 1.76% | +0.5% |
| Q1 2017 | $5,569,000 | +9.9% | 65,114 | +0.1% | 1.75% | +3.6% |
| Q4 2016 | $5,066,000 | +0.3% | 65,080 | +1.0% | 1.68% | -3.7% |
| Q3 2016 | $5,050,000 | -21.3% | 64,417 | +1.3% | 1.75% | -23.4% |
| Q2 2016 | $6,420,000 | +5.9% | 63,566 | -0.5% | 2.28% | +1.7% |
| Q1 2016 | $6,062,000 | +3.3% | 63,904 | +1.2% | 2.24% | +2.0% |
| Q4 2015 | $5,867,000 | +7.0% | 63,167 | -1.8% | 2.20% | +3.2% |
| Q3 2015 | $5,481,000 | -2.5% | 64,325 | -2.0% | 2.13% | +8.8% |
| Q2 2015 | $5,620,000 | -8.4% | 65,665 | -9.1% | 1.96% | -2.4% |
| Q1 2015 | $6,133,000 | -1.7% | 72,238 | -0.8% | 2.01% | -1.9% |
| Q4 2014 | $6,238,000 | +10.8% | 72,788 | -1.8% | 2.04% | +6.6% |
| Q3 2014 | $5,629,000 | -11.9% | 74,087 | -8.7% | 1.92% | -7.1% |
| Q2 2014 | $6,386,000 | +16.7% | 81,118 | +11.2% | 2.07% | +6.7% |
| Q1 2014 | $5,473,000 | -2.6% | 72,977 | +0.3% | 1.94% | -4.2% |
| Q4 2013 | $5,618,000 | +12.2% | 72,777 | +0.7% | 2.02% | -0.3% |
| Q3 2013 | $5,009,000 | +0.4% | 72,253 | -8.3% | 2.03% | +6.1% |
| Q2 2013 | $4,989,000 | – | 78,809 | – | 1.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |